Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2021-07-23

Original market date: See footnote 1

2013-02-19

Product name:

DYSPORT AESTHETIC

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02387735

Product Monograph/Veterinary Labelling:

Date: 2020-10-19 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

IPSEN BIOPHARMACEUTICALS CANADA INC
SUITE 505  5060 Spectrum Way
Mississauga
Ontario
Canada  L4W 5N5

Class: 

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Prescription,  Schedule D  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

92:92.00   OTHER MISCELLANEOUS THERAPEUTIC AGENTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

M03AX01  BOTULINUM TOXIN

Active ingredient group (AIG) number:See footnote 5

0153614001

List of active ingredient(s)
Active ingredient(s) Strength
ABOBOTULINUMTOXINA 300 UNIT / VIAL

Application information

Related information

Contact us

Version 3.9.0
Date modified: